Neoplasms, breast Trials in Nashville, United States
Conditions / Neoplasms, breast / Nashville, United States
Research into Neoplasms, breast spans multiple therapeutic approaches and trial phases.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00263588 | Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer | COMPLETED | PHASE2 |
| NCT00169533 | Rollover Study Of Lapatinib In Cancer Patients | COMPLETED | PHASE1 |
| NCT00051103 | Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin. | COMPLETED | PHASE2 |
| NCT00790816 | Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents | COMPLETED | PHASE1 |
| NCT00320385 | Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer | COMPLETED | PHASE3 |
| NCT00338247 | EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer | APPROVED_FOR_MARKETING | — |
| NCT00709761 | Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC | COMPLETED | PHASE2 |
| NCT01815294 | A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer | COMPLETED | PHASE1 |
| NCT01905592 | A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients | TERMINATED | PHASE3 |
| NCT00490139 | ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D | COMPLETED | PHASE3 |